Xiu Xuan Zhu
Corporate Officer/Principal bei Vivere Lifesciences Acquisition Corp.
Profil
Xiu Xuan Zhu is currently an Advisor at Vivere Lifesciences Acquisition Corp.
Previously, he held positions as Director-Liver Cancer Research at Massachusetts General Hospital Cancer Center, Director-Jiahui International Cancer Center at Jiahui International Clinics (HK) Co., Ltd., and President & Director at I-MAB Biopharma Co., Ltd.
He was also a Professor at Harvard Medical School.
Zhu holds a doctorate degree from The Trustees of Columbia University in The City of New York and Peking University Health Science Center.
Aktive Positionen von Xiu Xuan Zhu
| Unternehmen | Position | Beginn |
|---|---|---|
Vivere Lifesciences Acquisition Corp.
 Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Xiu Xuan Zhu
| Unternehmen | Position | Ende |
|---|---|---|
| I-MAB | Chief Executive Officer | 22.06.2023 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | President | - |
Jiahui International Clinics (HK) Co., Ltd.
 Jiahui International Clinics (HK) Co., Ltd. Hospital/Nursing ManagementHealth Services Jiahui International Clinics (HK) Co. Ltd. provides medical services. The firm healthcare network includes Jiahui Clinic for outpatient care, Jiahui International Hospital for tertiary care, and Jiahui Wellness. The company was founded by Cook David on April 30, 2015 and is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Massachusetts General Hospital Cancer Center
 Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Ausbildung von Xiu Xuan Zhu
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Peking University Health Science Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| I-MAB | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Health Services |
Jiahui International Clinics (HK) Co., Ltd.
Jiahui International Clinics (HK) Co., Ltd. Hospital/Nursing ManagementHealth Services Jiahui International Clinics (HK) Co. Ltd. provides medical services. The firm healthcare network includes Jiahui Clinic for outpatient care, Jiahui International Hospital for tertiary care, and Jiahui Wellness. The company was founded by Cook David on April 30, 2015 and is headquartered in Shanghai, China. | Health Services |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
Vivere Lifesciences Acquisition Corp.
Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Finance |
